Peter Angus

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

Peter Angus, Rhys Vaughan, Shelly Xiong et al. · Gastroenterology · 2003 · 567 citations

Life Sciences, Infectious Diseases, Molecular Biology +16

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations

Medicine, Internal Medicine, Pharmacotherapy +12

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Michael P. Manns, Didier Samuel, Edward Gane et al. · The Lancet Infectious Diseases · 2016 · 446 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +16

Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2

G. Paizis, Christos Tikellis, Mark E. Cooper et al. · Gut · 2005 · 339 citations · Full text

Medicine, Biochemistry, Pathobiology +15

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

Edward Gane, Stuart K. Roberts, Catherine AM Stedman et al. · The Lancet · 2010 · 336 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15